Patel, Ruchi P.; Ghilardi, Guido; Zhang, Yunlin; Chiang, Yi-Hao; Xie, Wei; Guruprasad, Puneeth; Kim, Ki Hyun; Chun, Inkook; Angelos, Mathew G.; Pajarillo, Raymone; Hong, Seok Jae; Lee, Yong Gu; Shestova, Olga; Shaw, Carolyn; Cohen, Ivan; Gupta, Aasha; Vu, Trang; Qian, Dean; Yang, Steven; Nimmagadda, Aditya; Snook, Adam E.; Siciliano, Nicholas; Rotolo, Antonia; Inamdar, Arati; Harris, Jaryse; Ugwuanyi, Ositadimma; Wang, Michael; Carturan, Alberto; Paruzzo, Luca; Chen, Linhui; Ballard, Hatcher J.; Blanchard, Tatiana; Xu, Chong; Abdel-Mohsen, Mohamed; Gabunia, Khatuna; Wysocka, Maria; Linette, Gerald P.; Carreno, Beatriz; Barrett, David M.; Teachey, David T.; Posey, Avery D.; Powell, Daniel J.; Sauter, C. Tor; Pileri, Stefano; Pillai, Vinodh; Scholler, John; Rook, Alain H.; Schuster, Stephen J.; Barta, Stefan K.; Porazzi, Patrizia; Ruella, Marco

Utilizing a surgical resection model for evaluating mRNA-based multi-antigen targeting CAR-T cell therapy against solid tumors

JOURNAL OF IMMUNOLOGY

IF3.4

2024-05-010

PRE

Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity

CELL STEM CELL

IF20.4

2024-04-010

PRE

Immunocytokines with specificity for invariant region of CAR molecules enhance effector function of multiple CAR T cell therapies

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Aberrant glycosylation in mPDAC is associated with increased epithelial-mesenchymal transition and recruitment of immunosuppressive cells

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Aberrant glycosylation in mPDAC cells is associated with increased recruitment of immunosuppressive cells

CANCER RESEARCH

IF16.6

2024-01-160

PRE

Forks in the road for CAR T and CAR NK cell cancer therapies

NATURE IMMUNOLOGY

IF27.6

2023-11-2736

PRE

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

鉴定高活性anti-CCR4 CAR T细胞治疗T细胞淋巴瘤

BLOOD ADVANCES

IF7.1

2023-07-1220

OAAI

PanCAR-specific antibody-cytokine fusion proteins

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Targeting solid cancers with a cancer-specific monoclonal antibody to surface expressed aberrant O-glycosylated proteins

CANCER RESEARCH

IF16.6

2023-04-040

PRE

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

多发性骨髓瘤细胞的表面组提示潜在的免疫治疗策略和耐药蛋白标志物

NATURE COMMUNICATIONS

IF15.7

2022-07-1546

OAAI

Ferguson, Ian D.; Patino-Escobar, Bonell; Tuomivaara, Sami T.; Lin, Yu-Hsiu T.; Nix, Matthew A.; Leung, Kevin K.; Kasap, Corynn; Ramos, Emilio; Vasquez, Wilson Nieves; Talbot, Alexis; Hale, Martina; Naik, Akul; Kishishita, Audrey; Choudhry, Priya; Lopez-Girona, Antonia; Miao, Weili; Wong, Sandy W.; Wolf, Jeffrey L.; Martin, Thomas G.; Shah, Nina; Vandenberg, Scott; Prakash, Sonam; Besse, Lenka; Driessen, Christoph; Posey, Avery D., Jr.; Mullins, R. Dyche; Eyquem, Justin; Wells, James A.; Wiita, Arun P.

Reprogramming T cells to target glycans and overcome glycan-mediated immunosuppression for cancer therapy

FASEB JOURNAL

IF4.2

2022-05-130

PRE

Leveraging CAR T cells to Achieve Desensitization and Enable Transplantation

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Sweet Immune Checkpoint Targets to Enhance T Cell Therapy

JOURNAL OF IMMUNOLOGY